January 15, 2016

January 15, 2016

Editorial: Mounting a moon-shot effort against cancer
Tampa Tribune – Jan. 14
Along with the Ohio State University Comprehensive Cancer Center, Moffitt initiated a national effort to improve access to the latest cancer therapies. The network is collecting data from hundreds of thousands of patients to study cancer at the molecular level in an effort to develop individualized treatments. 

The Ackerman Group ranks No. 1 Group in Sarasota County
New Tampa Patch – Jan. 14
Barbara is a lifetime board member of the Sarasota-Manatee Jewish Federation. The Group is also supports The Moffitt Cancer center, The Ringling Museum, All Faiths Food Bank, Forty Carrots, The Glasser/Schoenbaum Human Services Center and the Cystic Fibrosis Foundation. 

Mutation analysis in Chronic Myeloid Leukemia
OncLive – Jan. 14
Joining me today are my colleagues; Dr. Harry Erba, a professor of medicine and director of Hematologic Malignancy Program at The University of Alabama in Birmingham; Dr. Kevin Kelly, an associate professor of clinical medicine at the USC Norris Comprehensive Cancer Center at the University of Southern California; Dr. Javier Pinilla-Ibarz, an associate professor for the Department of Malignant Hematology at the Moffitt Cancer Center in Tampa, Florida; and Dr. David Snyder, the associate chair for the Department of Hematology and Hematopoietic Cell Transplantation at City of Hope in Duarte, California. 

Tampa's Moffitt center to play lead role in Biden's 'moon shot' to cure cancer
Tampa Bay Times – Jan. 14
The bold declaration was welcome news to Tampa's Moffitt Cancer Center. The nationally known research institute has already been talking to Biden's office about ways to realize the vision — and hopes to be a leader in the effort, executive vice president and center director Thomas Sellers said Wednesday.

Study will urge Fla. To boost its medical tourism profile
Travel Weekly – Jan. 13
After all, he said, the Sunshine State has famed medical facilities such as the Moffitt Cancer Center in Tampa, the University of Miami’s Sylvester Cancer Center and branches of the Mayo and Cleveland clinics, to name just a few. 

Local radiologist disagrees with latest mammogram recommendations
WFLA – Jan. 12
The US Preventive Services Task force finalized the guidelines claiming the chance of a false positive is both emotionally and financially expensive. However Dr. Bethany Niell at Moffitt Cancer Center is telling her patients not to wait.

TROD Medical receives CE Mark approval for Encage
BioSpace – Jan. 11
Clinical studies using the Encage device for treatment of prostate cancer are being performed at world renowned centers including: University College London (UCL) Hospitals, London; the J. Lee Moffitt Cancer Centre and Research Institute, Tampa, USA; the New York University (NYU) School of Medicine, NY, USA; and the Long Island Jewish (LIJ) School of Medicine, NY, USA.

Medical research organization renews lease at Tampa Palms
Commercial Property Executive – Jan. 11
Located within the Tampa Palms Community Development District, the 86,000-square-foot Class-A office building is surrounded by high-end residential developments and it is easily accessible to nearby major medical facilities including the University of South Florida, Florida Hospital, and the Moffitt Cancer Center. 

Florida Capitol 2016 Schedule: An epicenter of events
Tallahassee Democrat – Jan. 11
Moffitt Cancer Center: Dozens of cyclists will complete their 3-day, 300+ miles journey from Tampa to Tallahassee to kick off Moffitt Day 2016, a day that raises awareness of the toll cancer has on Florida's families & what Moffitt is dong to contribute to the cure. Kimberly Polacek – (813) 745.7408. 9 a.m. – 12 p.m. Front Steps of Historic Capitol

Smoking ban may face peer enforcement difficulties
The Oracle – Jan. 11
However, the USF system-wide ban started in 2009 with USF Health and the Moffitt Cancer Center. 

Estamos al comienzo de otro nivel de medicina, que intenta conocer más la base biológica de la enfermedad
Herencia Genetica Y Enfermedad – Jan. 9
Este estudio se denomina “Análisis de los factores pronósticos y aplicabilidad de los modelos pronósticos utilizados habitualmente en pacientes con SMD relacionados con el tratamiento“. Un estudio del International Working Group (IWG-PM) for Myelodysplastic Syndromes (MDS), en el que se han incluido más de 1.800 casos que provienen del registro español de SMD, del registro austríacoalemán, el registro suizo, el registro italiano y el de tres centros americanos: MD Anderson Cancer Center (Houston Texas), Lee Moffitt Cancer Center (Tampa; Florida) y Cleveland Clinic (Cleveland, Ohio).


Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.